DBCO-PEG3-GGFG-Exatecan is a Drug-linker conjugate for ADC. DBCO-PEG3-GGFG-Exatecan contains the ADC linker (DBCO-PEG3-GGFG) and a DNA topoisomerase I inhibitor Exatecan [1].
In Vitro, DCBPR2002-4 (DBCO-PEG3-GGFG-Exatecan construct) (72 h) can inhibit the viability of OVCAR-3 ovarian cancer cells expressing mesothelin in vitro, with its IC50 being 130.2 nM[1].
References:
[1]. CHUANG,Shih-Hsien, et al. Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof. WO2021248048 A2. 2021-12-09.
In Vitro, DCBPR2002-4 (DBCO-PEG3-GGFG-Exatecan construct) (72 h) can inhibit the viability of OVCAR-3 ovarian cancer cells expressing mesothelin in vitro, with its IC50 being 130.2 nM[1].
References:
[1]. CHUANG,Shih-Hsien, et al. Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof. WO2021248048 A2. 2021-12-09.
















